Transposagen’s FLASH™ XTN™ TALEN Nuclease Technology Featured in Genetic Engineering and Biotechnology News (GEN)

Apr 12 2014

Accessible XTN™ TAL Effectors Now Commercially Available. FLASH™ XTN™ TALEN Nuclease technology, discussed in GEN, shows incredible promise in producing "…high-precision and high-efficiency modifications in a target gene sequence to produce basic research tools and to enable dramatically improved gene therapy," according to Anton Simeonov of the NIH.(PRWEB) September 26, 2012 XTN™ TALE …

Related Blogs

    Originally posted 2012-10-02 12:51:39. Republished by Blog Post Promoter

    No responses yet

    Leave a Reply